Genome wide association studies for treatment‐related adverse effects of pediatric acute lymphoblastic leukemia
- 5 October 2020
- journal article
- review article
- Published by Wiley in WIREs Mechanisms of Disease
- Vol. 13 (3) , e1509
Abstract
Acute lymphoblastic leukemia (ALL) is the most common pediatric hematological malignancy; notwithstanding the success of ALL therapy, severe adverse drugs effects represent a serious issue in pediatric oncology, because they could be both an additional life threatening condition for ALL patients per se and a reason to therapy delay or discontinuation with important fallouts on final outcome. Cancer treatment‐related toxicities have generated a significant need of finding predictive pharmacogenomic markers for the a priori identification of at risk patients. In the era of precision medicine, high throughput genomic screening such as genome wide association studies (GWAS) might provide useful markers to tailor therapy intensity on patients' genetic profile. Furthermore, these findings could be useful in basic research for better understanding the mechanistic and regulatory pathways of the biological functions associated with ALL treatment toxicities. The purpose of this review is to give an overview of high throughput genomic screening of the last 10 years that had investigated the landscape of ALL treatment‐associated toxicities.This article is categorized under: Cancer > Genetics/Genomics/EpigeneticsKeywords
This publication has 136 references indexed in Scilit:
- Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing: 2013 UpdateClinical Pharmacology & Therapeutics, 2013
- Defective Presynaptic Choline Transport Underlies Hereditary Motor NeuropathyThe American Journal of Human Genetics, 2012
- Molecular genetic studies of complex phenotypesTranslational Research, 2012
- Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritisNature Genetics, 2012
- Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine DosingClinical Pharmacology & Therapeutics, 2011
- Prioritizing GWAS Results: A Review of Statistical Methods and Recommendations for Their ApplicationThe American Journal of Human Genetics, 2010
- A randomized, controlled, double‐blind, pilot study of milk thistle for the treatment of hepatotoxicity in childhood acute lymphoblastic leukemia (ALL)Cancer, 2009
- Finding the missing heritability of complex diseasesNature, 2009
- SUN1/2 and Syne/Nesprin-1/2 Complexes Connect Centrosome to the Nucleus during Neurogenesis and Neuronal Migration in MiceNeuron, 2009
- Cep72 regulates the localization of key centrosomal proteins and proper bipolar spindle formationThe EMBO Journal, 2009